U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07349758) titled 'Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers' on Jan. 15.
Brief Summary: The goal of this study is to evaluate the pharmacokinetics of a one-time dosing of two F/TAF tablets over a 14-day period.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
HIV Prevention
Intervention:
DRUG: tenofovir alafenamide [TAF] 50 mg/emtricitabine [FTC] 400mg
One-time dose of two F/TAF tablets
Recruitment Status: RECRUITING
Sponsor: Johns Hopkins University
Disclaimer: Curated by HT Syndication....